IL1F10 and psoriasis: Additionally, the regulatory effects of IL-38 on IL-17-mediated inflammation were examined in murine models of imiquimod-induced psoriasis, with IL-38 KO mice displaying increased IL-17 production in addition to increased dermal neutrophil infiltration [60].